Concepedia
Statistics
Publications
132
Citations
12.2K
H-Index
57
Active since
1980
Affiliations
Abbott Fund(Current)
Abbott (United Kingdom)
Abbott (United States)
AbbVie (United States)
National Institutes of Health
Dale J. Kempf is an author at Abbott Fund specializing in medicine, pharmacology, and hiv.
Top concepts
MedicinePharmacologyDrug DiscoveryHivBiochemistryNatural SciencesVirologyImmunologyMedicinal ChemistryPharmacotherapy
Publications per year
1980–2021
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
Akhteruzzaman Molla, Marina Korneyeva, Qing Gao et al. · Nature Medicine · 1996 · 766 citations
Viral Replication, Ordered Accumulation, Natural Sciences +10
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Sarah Palmer, Frank Maldarelli, Ann Wiegand et al. · Proceedings of the National Academy of Sciences · 2008 · 641 citations · Full text
Low-level Viremia Persists, Immunology, Antiviral Drug +16
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.
Dale J. Kempf, Kennan C. Marsh, Jon F. Denissen et al. · Proceedings of the National Academy of Sciences · 1995 · 551 citations · Full text
Design, Activity, and 2.8 Å Crystal Structure of a <i>C</i> <sub>2</sub> Symmetric Inhibitor Complexed to HIV-1 Protease
John W. Erickson, David J. Neidhart, John H. VanDrie et al. · Science · 1990 · 528 citations · Full text
ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease
Hing L. Sham, Dale J. Kempf, Akhteruzammen Molla et al. · Antimicrobial Agents and Chemotherapy · 1998 · 468 citations · Full text
1–5 of 132